Members of the Brazilian government are examining the proposal about planting cannabis throughout the country. The effort, however, might be halted by the Evangelical Bench, which rejects corporate cannabis cultivation. In the treatment group, 43% were in favor, 48.3% were against and 8.7% were neither in favor nor against. Deputies are less likely to accept the argument for cannabis in Brazil.
Parliamentarians are less open to planting cannabis in Brazil than the general population. Furthermore, unlike the general population, calling it “medical cannabis” doesn’t change the position of federal deputies.
In general, congressmen are divided on the issue. About half are in favor of legalization, while the other half are against it.
Hemp.im provides you with the most current and up-to-date marijuana news and covers wide-ranging topics including hemp and cannabis stocks; hemp products like hemp milk, hemp protein, hemp gummies, creams, buds, and extracts; hemp farming and countless additional hemp products and services.
Medical treatment raises citizen support for planting cannabis in Brazil
The law portal JOTA conducted the same experiment to measure support for the legalization of cannabis planting in Brazil with the population and parliamentarians.
On Jan. 6, JOTA Labs showed that the legalization of cannabis gains much more support among the Brazilian population when associated with medical use.
The data is part of an experimental study made by JOTA in its most recent research in partnership with the Brazilian Institute of Research and Data Analysis.
The decision to legalize cannabis in Brazil
Like the rest of the population, a group of MPs received the following question: Are you for or against planting cannabis in Brazil?
The second group, the treatment group, were presented with the following question: are you for or against the cultivation of marijuana in the country for medical purposes?
In the control group, 45.9% said they were in favor of legalization, 45.7% said they were against and 8.4% said they were neither in favor nor against.
In the treatment group, 43% were in favor, 48.3% were against and 8.7% were neither in favor nor against.
What does the data suggest?
The comparison between the data from the general population and parliamentarians shows that there is greater resistance among politicians to the legalization of planting cannabis in Brazil for medical purposes.
In the control group, the support for the legalization of cannabis is independent of medical use and the results are very similar among Brazilians in general and among deputies.
What the experimental study showed is that the deputies are less likely to accept the argument for planting cannabis in Brazil for medical use.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in SECHAT, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.